CBio A/S: Financial statements 2022
CVR: 40216642
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
CBio A/S (CVR 40216642) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -1,104,139 and a net result of DKK -8,975,691 compared with DKK -8,556,249 the year before. Equity in the 2022 report amounted to DKK -710,280. The company had 11 employees in the financial year.
- Gross Profit
- DKK -1,104,139
- Profit/Loss
- DKK -8,975,691
- Equity
- DKK -710,280
- Total Assets
- DKK 14,750,132
- Employees
- 11
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -1.1 mio. | -9 mio. | -710 t. | 11 |
| 2021 | - | -1.9 mio. | -8.6 mio. | 8.3 mio. | 11 |
| 2020 | - | -1.8 mio. | -3.9 mio. | 6.8 mio. | 4 |
| 2019 | - | -346 t. | -277 t. | 723 t. | 0 |
Official annual report
Keep an eye on CBio A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
CBio A/S has published its annual report for 2021. Gross profit came to DKK -1,913,052, and the net result was DKK -8,556,249.
About CBio A/S
CBio A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Cordes Biotech A/S. The management consists of Ulrik Cordes. The board consists of Else Beth Trautner (chair), Christian Henri Leroy, Karin Cecilia Hultén and Lars Rabe Tønnesen. The company's owners include Leroy Capital Fund II Aps, Bildbar ApS and CBio Holding ApS. The company has 8 employees (2026). In 2025, the company reported a gross profit of DKK 3,671,653 and a net result of DKK -1,802,853 compared with DKK -79,605 the year before. Equity in the 2025 report amounted to DKK 10,475,706.